BIO-TECHNE Corp
Global supplier of reagents and instruments for research and clinical diagnostic markets.
TECH | US
Overview
Corporate Details
- ISIN(s):
- US09073M1045
- LEI:
- Country:
- United States of America
- Address:
- 614 MCKINLEY PL N E, 55413 MINNEAPOLIS
- Website:
- https://www.bio-techne.com/
- Sector:
- Manufacturing
Description
Bio-Techne Corporation is a global developer, manufacturer, and supplier of high-quality reagents, analytical instruments, and services for the research and clinical diagnostic markets. The company's portfolio includes a wide range of life science tools such as recombinant proteins, antibodies, and immunoassays offered through its family of brands. Bio-Techne also provides automated platforms for protein characterization, including Simple Western and iCE systems, alongside next-generation Simple Plex assays. The company supports scientific discovery and accelerates the development of cell and gene therapies by delivering solutions focused on reproducibility and consistency, complemented by custom manufacturing and testing services.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-14 13:19 | English | 8.5 KB | |||
| 2025-11-05 17:46 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
English | 8.9 KB | ||
| 2025-11-05 17:46 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
English | 8.9 KB | ||
| 2025-11-05 17:46 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
English | 8.8 KB | ||
| 2025-11-05 17:31 |
10-Q
|
English | 1.6 MB | ||
| 2025-11-05 07:31 |
8-K
|
English | 161.2 KB | ||
| 2025-11-03 18:38 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
English | 7.8 KB | ||
| 2025-11-03 18:37 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
English | 8.0 KB | ||
| 2025-11-03 18:25 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
English | 8.0 KB | ||
| 2025-11-03 18:25 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
English | 7.6 KB | ||
| 2025-11-03 18:24 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
English | 8.7 KB | ||
| 2025-11-03 18:23 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
English | 7.4 KB | ||
| 2025-11-03 18:23 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
English | 7.9 KB | ||
| 2025-11-03 18:22 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
English | 7.9 KB | ||
| 2025-09-19 09:07 |
ANNUAL REPORT TO SECURITY HOLDERS
|
English | 2.9 MB |
Automate Your Workflow. Get a real-time feed of all BIO-TECHNE Corp filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BIO-TECHNE Corp
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BIO-TECHNE Corp via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
